...
首页> 外文期刊>Clinical Interventions in Aging >Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly
【24h】

Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly

机译:18F-FDG PET / CT联合碳水化合物抗原19-9在中国老年人慢性胰腺炎和胰腺癌鉴别中的应用

获取原文
           

摘要

Objective: The current study was designed to analyze the value of 18F-FDG positron emission tomography/computed tomography (PET/CT) combined with carbohydrate antigen 19-9 (CA19-9) in differentiating pancreatic carcinoma (PC) from chronic mass-forming pancreatitis (CMFP) in Chinese elderly. Methods: As it is impossible to differentially diagnose PC from CMFP, 60 participants older than 65 years with focal pancreatic lesions were scanned by 18F-FDG PET/CT and their CA19-9 levels were tested. Diagnoses of all participants were confirmed by comprehensive methods including aspiration biopsy, surgical pathology, and clinical follow-up of 12 months. Twenty participants with CMFP were included in CMFP group and 40 participants with PC in PC group. Results: In CMFP and PC groups, 46 participants showed increased 18F-FDG uptake, 43 had elevated CA19-9 levels, and 38 participants had both increased 18F-FDG uptake and elevated CA19-9 levels. Standardized uptake value maximum of PC group (5.98±2.27) was significantly different from CMFP group (2.58±1.81, P <0.05). Sensitivity, specificity, and accuracy of 18F-FDG PET/CT in differentiating PC from CMFP were 95%, 60%, and 83.3%, respectively. CA19-9 levels of PC group (917.44±1,088.24) were significantly different from CMFP group (19.09±19.54, P <0.05). Sensitivity, specificity, and accuracy of CA19-9 levels in differentiating PC from CMFP were 87.5%, 60%, and 78.3%, respectively. Sensitivity, specificity, and accuracy of 18F-FDG PET/CT combined with CA19-9 levels in differentiating PC from CMFP were 90%, 90%, and 90%, respectively. Conclusion: 18F-FDG PET/CT had reliable sensitivity, specificity, and accuracy in differentiating PC from CMFP, and CA19-9 levels could be helpful in 18F-FDG PET/CT for differentiating PC from CMFP in Chinese elderly. Moreover, 18F-FDG PET/CT combined with CA19-9 levels was found to be an effective method to differentially diagnose PC from CMFP and has paved the way for the timely and safe treatment of PC and CMFP in Chinese elderly.
机译:目的:本研究旨在分析18F-FDG正电子发射断层扫描/计算机断层扫描(PET / CT)结合碳水化合物抗原19-9(CA19-9)在区分胰腺癌(PC)与慢性形成中的价值中国老年人胰腺炎(CMFP)。方法:由于无法从CMFP鉴别PC,因此用18F-FDG PET / CT对60名65岁以上的局灶性胰腺病变参与者进行了扫描,并测试了其CA19-9水平。所有参与者的诊断均通过包括活检,手术病理和12个月临床随访在内的综合方法得到证实。 CMFP组中有20名CMFP参与者,PC组中有40名PC参与者。结果:在CMFP和PC组中,有46名参与者显示18F-FDG摄取增加,43名CA19-9水平升高,而38名参与者同时增加18F-FDG摄取和CA19-9水平。 PC组的最大标准摄取值(5.98±2.27)与CMFP组的差异最大(2.58±1.81,P <0.05)。 18F-FDG PET / CT区分PC和CMFP的灵敏度,特异性和准确性分别为95%,60%和83.3%。 PC组CA19-9水平(917.44±1,088.24)与CMFP组差异显着(19.09±19.54,P <0.05)。区分PC和CMFP的CA19-9水平的敏感性,特异性和准确性分别为87.5%,60%和78.3%。 18F-FDG PET / CT结合CA19-9水平在区分PC和CMFP方面的敏感性,特异性和准确性分别为90%,90%和90%。结论:18F-FDG PET / CT在鉴别PC和CMFP方面具有可靠的敏感性,特异性和准确性,CA19-9水平有助于18F-FDG PET / CT鉴别中国老年人与CMFP的PC。此外,发现18F-FDG PET / CT结合CA19-9水平是鉴别CMFP与PC的有效方法,为及时,安全地治疗中国老年人PC和CMFP铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号